Showing results (111-120 of 152) with videos related to

Sort By:
Pageof 16
Antimicrobial Agents and Chemotherapy|September 27, 2022
Antibiotic Prophylaxis for Megaprosthetic Reconstructions: Drug and Dosing May Matter More than DurationIsabelle S Byers, Nicholas A Turner, Nicole L Levine, et al.
Gynecologic Oncology|March 31, 2024
High-dose ascorbate exerts anti-tumor activities and improves inhibitory effect of carboplatin through the pro-oxidant function pathway in uterine serous carcinoma cell linesXiaochang Shen, Jiandong Wang, Boer Deng, et al.
Nano Letters|July 15, 2022
Genetically Engineered Nanoparticles of Asymmetric Triblock Polypeptide with a Platinum(IV) Cargo Outperforms a Platinum(II) Analog and Free Drug in a Murine Cancer ModelSoumen Saha, Samagya Banskota, Jianqiao Liu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 24, 2006
A tracer dose of technetium-99m-labeled liposomes can estimate the effect of hyperthermia on intratumoral doxil extravasationMiriam M Kleiter, Daohai Yu, Lenore A Mohammadian, et al.
Radiation Research|December 2, 2020
Manganese Porphyrin and Radiotherapy Improves Local Tumor Response and Overall Survival in Orthotopic Murine Mammary Carcinoma ModelsMary-Keara Boss, Rebecca E Oberley-Deegan, Ines Batinic-Haberle, et al.
Mbio|September 22, 2023
Enhanced fungal specificity and in vivo therapeutic efficacy of a C-22-modified FK520 analog against C. neoformansAngela Rivera, Won Young Lim, Eunchong Park, et al.
Biorxiv : the Preprint Server for Biology|June 19, 2023
Enhanced fungal specificity and in vivo therapeutic efficacy of a C-22 modified FK520 analog against C. neoformansAngela Rivera, Won Young Lim, Eunchong Park, et al.
Environmental and Molecular Mutagenesis|May 26, 2016
Neurobehavioral radiation mitigation to standard brain cancer therapy regimens by Mn(III) n-butoxyethylpyridylporphyrin-based redox modifierDouglas H Weitzel, Artak Tovmasyan, Kathleen A Ashcraft, et al.
Pediatric Blood & Cancer|December 31, 2016
A phase I study of perifosine with temsirolimus for recurrent pediatric solid tumorsOren J Becher, Stephen W Gilheeney, Yasmin Khakoo, et al.
Free Radical Biology & Medicine|June 1, 2015
A comprehensive evaluation of catalase-like activity of different classes of redox-active therapeuticsArtak Tovmasyan, Clarissa G C Maia, Tin Weitner, et al.
Pageof 16